Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work? - Wikidata - wikimedia - TriplyDB

Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?

Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?

http://www.wikidata.org/entity/Q37968531

about

The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms New Therapeutic Approaches in Polycythemia Vera Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms.Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia.Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial.Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes.BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells.JAK2 inhibitors in the treatment of myeloproliferative neoplasms.Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies.Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells.

P2860

Q26779929-4D4F549E-D489-41F5-9A2E-A3F2873881EE Q26795677-449A5DFE-6A5F-4DBD-8B55-BC1B04FDD6E6 Q34302770-FD925F30-FB97-478A-BF93-C2A199156362 Q35188877-EAC7FFF1-0B2E-41BE-A298-B209B6523B56 Q35244917-C14CB1EE-A8BE-4028-BBEC-43A29F0F509C Q37548944-F648B16C-974F-4885-AB4E-E5C9700E6A09 Q37693266-261F1945-829F-411C-8362-D2C449DAB758 Q38044736-1FDF0301-BB27-4E6F-8F84-BC6FCDCC3449 Q38349213-E75B1273-BC7E-472F-8612-60072298ECFF Q41135028-1ADA5C0E-640F-46EF-99E1-D931C43C70F8 Q41190385-290FFC8A-F0E4-4EF3-A6CC-56966B26538A

P2860

Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?

http://www.wikidata.org/entity/Q37968531

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Transformation of a chronic my ...... leukemia: does anything work?

@en

Transformation of a chronic my ...... leukemia: does anything work?

@nl

type

label

Transformation of a chronic my ...... leukemia: does anything work?

@en

Transformation of a chronic my ...... leukemia: does anything work?

@nl

prefLabel

Transformation of a chronic my ...... leukemia: does anything work?

@en

Transformation of a chronic my ...... leukemia: does anything work?

@nl

P1433

Q37968531-D156BFDD-2005-479D-9DFC-21039F19C192

P1476

Q37968531-67482A7B-A443-417C-BA8B-7F546873DFEB

P2093

Q37968531-2BB3E043-6FE5-4075-B4C6-4D0D917F9EE0

Q37968531-3783DC8B-A4AD-4281-92E4-0E73AF1EC986

Q37968531-62974C0A-2B4E-4720-8111-72F38295F6CC

P2860

Q37968531-0428C6F9-1F38-47D5-AA2A-992DE83EC24D

Q37968531-19F467B2-BE21-4562-B044-25DB0E375B21

Q37968531-1FE74831-B00C-4DDD-B060-72C9875AB871

Q37968531-25C13372-26A8-4930-B9CF-C15736B6BDA4

Q37968531-2A34DFFA-3A6A-4B9E-97AF-B57F8C60CBD5

Q37968531-348BA694-A4C6-4E0E-AEE7-1E9BC1A366A0

Q37968531-396571D0-3C67-42C7-90F5-FFD3058EFA17

Q37968531-399BA1B5-5305-4F63-A20F-CA1E60130206

Q37968531-3AAC1F23-4782-4DBB-9E43-8D232F4832C4

Q37968531-3C31AE49-5837-4FF9-B9B9-C96404C13429

P2888

Q37968531-BDB3B59F-2B5E-4CA4-B451-757A58294B99

P304

Q37968531-4F435E50-C06C-42D6-80E3-99957267F37E

P31

Q37968531-BA0E381C-0610-4796-87E6-20EE0A90F493

P356

Q37968531-13540CF8-A873-4BE8-8F88-A4029B006E73

P433

Q37968531-A6EC8222-B13E-401B-8FDB-10BC99EA7F84

P478

Q37968531-A86E55C0-6DE3-4522-9333-9BCE44D3F94B

P577

Q37968531-2D217DC1-FC1D-44D5-AFCD-B2CF493E6A4E

P698

Q37968531-449652F3-DE6E-4805-88E6-4469146A032E

P921

Q37968531-F39972ED-02D1-4486-B041-D9F5BCAA005A

P356

S11899-011-0107-9

P1433

Current hematologic malignancy reports

P1476

Transformation of a chronic my ...... leukemia: does anything work?

@en

P2093

Madappa N Kundranda

http://www.w3.org/2001/XMLSchema#string

Raoul Tibes

http://www.w3.org/2001/XMLSchema#string

Ruben A Mesa

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

A road map for those who don't know JAK-STAT

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

A gain-of-function mutation of JAK2 in myeloproliferative disorders

Nuclear translocation of urokinase-type plasminogen activator

P2888

s11899-011-0107-9

P304

78-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11899-011-0107-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22170483

http://www.w3.org/2001/XMLSchema#string

P921